Trial Profile
Phase III trial of ubidecarenone for squamous cell cancer planned.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 21 Mar 2023
Price :
$35
*
At a glance
- Drugs Ubidecarenone (Primary)
- Indications Squamous cell cancer
- Focus Therapeutic Use
- 08 Feb 2023 According to a BPG Bio media release, Berg Pharma has been acquired by BPG Bio.
- 11 Apr 2012 New trial record